logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO-GU 2020 — Localized prostate cancer: long-term data support hypofractionated radiotherapy

8-year CHHiP trial follow-up confirms non-inferiority of the 60-Gy regimen.